| Criterion Text | Inclusion/Exclusion | Disease | Biomarker | Prior Therapy | Criterion Rule |
| --- | --- | --- | --- | --- | --- |
| Known additional malignancy within 2 years prior to enrollment with the exception of curatively treated basal cell carcinoma of the skin, squamous cell carcinoma of the skin and/or curatively resected in situ cancers | Exclusion | Basal cell carcinoma | - | - | - |

Note:

* Criterion Text: The verbatim snippet of the exclusion criterion.
* Inclusion/Exclusion: Denotes whether the criterion is an inclusion or exclusion criterion.
* Disease: The name of the disease or condition mentioned in the criterion. In this case, Basal cell carcinoma is the only disease mentioned.
* Biomarker: No biomarker is mentioned in this criterion.
* Prior Therapy: No prior therapy is mentioned in this criterion.
* Criterion Rule: A logical expression that could be interpreted programmatically. In this case, the rule is simply "known additional malignancy within 2 years prior to enrollment" with the exception of certain types of skin cancer.